224 related articles for article (PubMed ID: 33198776)
1. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
[TBL] [Abstract][Full Text] [Related]
2. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
3. OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3.
Hu H; Brittain GC; Chang JH; Puebla-Osorio N; Jin J; Zal A; Xiao Y; Cheng X; Chang M; Fu YX; Zal T; Zhu C; Sun SC
Nature; 2013 Feb; 494(7437):371-4. PubMed ID: 23334419
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
5. OTU deubiquitinase 7B facilitates the hyperthermia-induced inhibition of lung cancer progression through enhancing Smac-mediated mitochondrial dysfunction.
Sun C; Bai J; Sun J; Sun Y; Zhang F; Li H; Liu Y; Meng L; Wang X
Environ Toxicol; 2024 Apr; 39(4):1989-2005. PubMed ID: 38088504
[TBL] [Abstract][Full Text] [Related]
6. Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway.
He JQ; Saha SK; Kang JR; Zarnegar B; Cheng G
J Biol Chem; 2007 Feb; 282(6):3688-94. PubMed ID: 17158868
[TBL] [Abstract][Full Text] [Related]
7. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.
Vallabhapurapu S; Matsuzawa A; Zhang W; Tseng PH; Keats JJ; Wang H; Vignali DA; Bergsagel PL; Karin M
Nat Immunol; 2008 Dec; 9(12):1364-70. PubMed ID: 18997792
[TBL] [Abstract][Full Text] [Related]
8. LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling.
Afsahi A; Silvestri CM; Moore AE; Graham CF; Bacchiochi K; St-Jean M; Baker CL; Korneluk RG; Beug ST; LaCasse EC; Bramson JL
Front Immunol; 2023; 14():1179827. PubMed ID: 37138866
[TBL] [Abstract][Full Text] [Related]
9. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
10. Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.
Shekhar TM; Burvenich IJG; Harris MA; Rigopoulos A; Zanker D; Spurling A; Parker BS; Walkley CR; Scott AM; Hawkins CJ
BMC Cancer; 2019 Sep; 19(1):924. PubMed ID: 31521127
[TBL] [Abstract][Full Text] [Related]
11. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.
Ding J; Qin D; Zhang Y; Li Q; Li Y; Li J
Mol Med Rep; 2020 Mar; 21(3):1251-1257. PubMed ID: 31922244
[TBL] [Abstract][Full Text] [Related]
12. The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways.
Muro I; Fang G; Gardella KA; Mahajan IM; Wright CW
Cell Cycle; 2014; 13(12):1918-27. PubMed ID: 24739416
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
Liao G; Zhang M; Harhaj EW; Sun SC
J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
[TBL] [Abstract][Full Text] [Related]
14. OTUD7B and NIK expression in non-small cell lung cancer: Association with clinicopathological features and prognostic implications.
Zhang B; Wang H; Yang L; Zhang Y; Wang P; Huang G; Zheng J; Ren H; Qin S
Pathol Res Pract; 2016 Oct; 212(10):893-898. PubMed ID: 27499151
[TBL] [Abstract][Full Text] [Related]
15. IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms.
Zhou L; Zhang Y; Meads MB; Dai Y; Ning Y; Hu X; Li L; Sharma K; Nkwocha J; Parker R; Bui D; McCarter J; Kramer L; Purcell C; Sudalagunta PR; Canevarolo RR; Coelho Siqueira Silva MD; De Avila G; Alugubelli RR; Silva AS; Kmeiciak M; Ferreira-Gonzalez A; Shain KH; Grant S
Blood Adv; 2021 Oct; 5(19):3776-3788. PubMed ID: 34464977
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury.
Jiang B; Shen H; Chen Z; Yin L; Zan L; Rui L
J Biol Chem; 2015 May; 290(18):11704-14. PubMed ID: 25792747
[TBL] [Abstract][Full Text] [Related]
17. Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
Zarnegar BJ; Wang Y; Mahoney DJ; Dempsey PW; Cheung HH; He J; Shiba T; Yang X; Yeh WC; Mak TW; Korneluk RG; Cheng G
Nat Immunol; 2008 Dec; 9(12):1371-8. PubMed ID: 18997794
[TBL] [Abstract][Full Text] [Related]
18. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
Shiode Y; Kodama T; Shigeno S; Murai K; Tanaka S; Newberg JY; Kondo J; Kobayashi S; Yamada R; Hikita H; Sakamori R; Suemizu H; Tatsumi T; Eguchi H; Jenkins NA; Copeland NG; Takehara T
Hepatology; 2023 Feb; 77(2):395-410. PubMed ID: 34995376
[TBL] [Abstract][Full Text] [Related]
19. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
[TBL] [Abstract][Full Text] [Related]
20. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma.
Li MY; Chong LC; Duns G; Lytle A; Woolcock B; Jiang A; Telenius A; Ben-Neriah S; Nawaz W; Slack GW; Elisia I; Viganò E; Aoki T; Healy S; Krystal G; Venturutti L; Scott DW; Steidl C
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2320421121. PubMed ID: 38662551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
